Trial NCT04606576

View at ClinicalTrials.gov 
Org. Study IDs: ORA-D-013-1

Last trial update was posted on 2023-02-09

MeSH Interventions

Insulin Insulin, Globin Zinc

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions

Type 2 Diabetes Mellitus

Stopping Reasons

ORA-D-013-1 was terminated based on the primary results analyzed at the end of the treatment, week 26.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID